ENHO and atrial fibrillation: We compared the predictive models for clinical outcome and established that the model 1 (UACR ≥16.5 mg/g Cr) and the model 2 (AF) did not differ each another in prediction of AKI, whereas the model 3 (NT-proBNP≥19,540 pmol/mL) and the model 4 (adropin<2.10 ng/mL) were significantly better than the reference value of the model 1 (Table 4).